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Abstract
Background: Quantile and rank normalizations are two widely used pre-processing techniques designed to remove
technological noise presented in genomic data. Subsequent statistical analysis such as gene diﬀerential expression
analysis is usually based on normalized expressions. In this study, we ﬁnd that these normalization procedures can
have a profound impact on diﬀerential expression analysis, especially in terms of testing power.
Results: We conduct theoretical derivations to show that the testing power of diﬀerential expression analysis based
on quantile or rank normalized gene expressions can never reach 100% with ﬁxed sample size no matter how strong
the gene diﬀerentiation eﬀects are. We perform extensive simulation analyses and ﬁnd the results corroborate
theoretical predictions.
Conclusions: Our ﬁnding may explain why genes with well documented strong diﬀerentiation are not always
detected in microarray analysis. It provides new insights in microarray experimental design and will help practitioners
in selecting proper normalization procedures.
Background
Microarray technology has been widely adopted in many
genomic related studies in the past decade. Despite its
popularity, it is well known that various technical noises
exist in microarray experiments [1,2] due to the limi-
tation of technology. As a remedy, many normalization
procedures have been proposed to remove these system-
atic noises, thus improving the detection of diﬀerentially
expressed genes. Some eﬀorts have been made to evaluate
diﬀerent normalization procedures [3-6]. Interested read-
ers are referred to [7,8] for background and more detailed
reviews of normalization procedures.
Quantile normalization is perhaps the most widely
adopted method for analyzing microarray data generated
by Aﬀymetrix GeneChip platform.Motivated by quantile-
quantile plot, it makes the empirical distribution of gene
expressions pooled from each array to be the same [3].
It is the default option of BioConductor [9], which is a
*Correspondence: huruizg@hotmail.com
Department of Biostatistics and Computational Biology, University of
Rochester, 601 Elmwood Avenue, Box 630, Rochester, New York 14642, USA
very popular open source software for analyzing microar-
ray data implemented in R [10], the de facto standard
statistical computing language in the statistical research
community. This algorithm is also used for normalizing
Aﬀymetrix exon arrays [11,12], Illumina BeadChip arrays
[13-15], Illumina transcriptome sequencing (mRNA-Seq)
data [16], Illumina Inﬁnium whole genome genotyping
(WGG) arrays [17], and Solexa/Illumina deep sequenc-
ing technology [18], etc. In addition, several other popular
normalization procedures are variants of quantile nor-
malization, such as the enhanced quantile normalization
[19] and subset quantile normalization [20] designed for
microarrays, and the conditional quantile normalization
[21] designed primarily for normalizing RNA-seq data.
Rank normalization is an alternative to quantile nor-
malization. It replaces each observation by its frac-
tional rank (the rank divided by the total number of
genes) within array [22,23]. This normalization pro-
cedure achieves robustness to non-additive noise at
the expense of losing some parametric information
of expressions.
After normalization, a pertinent statistical test such as
Student’s t-test [24] is applied to these normalized gene
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expression levels. The resulting p-values are adjusted by
a multiple testing procedure (MTP) in order to con-
trol certain quantity of per-family Type I error, such as
family-wise error rate (FWER) [25-28] and false discov-
ery rate (FDR) [29]. Diﬀerentially expressed genes are
identiﬁed based on a pre-speciﬁed threshold of adjusted
p-values. More detailed introduction of statistical meth-
ods for detecting diﬀerentially expressed genes can be
found in [30-33].
Without compromising the control of type I error,
better testing power can be achieved by either increas-
ing sample size or improving the strength of gene
diﬀerentiation eﬀect (fold changes between diﬀerent phe-
notypes). Sometimes large expected diﬀerential eﬀects
based on biological considerations are invoked as a rea-
son to justify a microarray study with very small sample
sizes.
In this study, we ﬁnd that one cannot “trade” dif-
ferentiation eﬀects with sample size. When the sam-
ple size is small, the statistical power for a gene
diﬀerentiation analysis will not reach 100% even when
the eﬀect size approaches to inﬁnity. This counter-
intuitive phenomenon is due to the nature of the
normalization procedures, which alters both sample
mean diﬀerence and pooled sample standard devia-
tion of the normalized expressions. As a result, they
both grow at most linearly as functions of eﬀect size
and their eﬀects cancel out. Our ﬁndings provide new
insights into microarray experimental design which may
help practitioners in selecting appropriate normalization
procedures.
Methods
Notations and biological data
Notations
We assume that all expression levels are log-transformed.
For convenience, the words “gene” and “gene expression”
are used interchangeably to refer to these log-transformed
random variables. These genes are indexed by i =
1, 2, . . . ,m, wherem is the total number of genes.
Let c = A,B be two diﬀerent phenotypic groups. For
simplicity we assume that the number of arrays in both
groups are the same and denoted by n. Without loss of
generality, phenotypic group A is set to represent the phe-
notype of interest (usually the disease or the treatment
group) and group B the normal phenotype. So up (down)
regulation of a gene refers to its over (under) expression
in group A. We denote by ycij the observed expression level
of the ith gene recorded on the jth array sampled from the
cth phenotypic group. The normalized counterpart of ycij
is written as y∗cij .





= μci and var(ycij) = σ 2ic, respectively. Their







)2 = 1n−1 ∑nj=1(y∗cij − y¯∗ci· )2, respec-
tively.
In practice, the true level of gene diﬀerentiation is not
a constant. It depends on the biological settings. The
variance of gene expressions is nor constant either — it
depends on the accuracy of measuring instruments and
the homogeneity of biological subjects, just to name a
few factors. In terms of statistical power, the decrease of
gene expression variance is equivalent to the increase of
mean diﬀerence. For simplicity, we consider gene expres-
sion variance to be ﬁxed and deﬁne the eﬀect size, our
analysis tuning parameter, to be the expected mean diﬀer-
ence of the ith gene expression between two phenotypes
ei := μAi − μBi .
We divide genes into three sets:
• G0, the set of non-diﬀerentially expressed genes
(abbreviated as NDEGs). For all i ∈ G0,
ei := μAi − μBi = 0.• G+1 , the set of up-regulated genes. For all i ∈ G+1 ,
ei > 0.
• G−1 , the set of down-regulated genes. For all i ∈ G−1 ,
ei < 0.
The set of diﬀerentially expressed genes (abbreviated
as DEGs) is the union of both up-regulated and down-
regulated genes, which is denoted by G1 = G+1 ∪ G−1 . We
write the size of these gene sets bym0 = |G0|,m+1 = |G+1 |,
m−1 = |G−1 |, and m1 = |G1|. Apparently m1 = m+1 + m−1
andm0 + m1 = m.
Biological data
The biological dataset used in this study is the childhood
leukemia dataset from the St. Jude Children’s Research
Hospital database [34]. We select three groups of data:
88 patients (arrays) with hyperdiploid acute lymphoblastic
leukemia (HYPERDIP), 79 patients (arrays) with a spe-
cial translocation type of acute lymphoblastic leukemia
(TEL) and 45 patients (arrays) with a T lineage leukemia
(TALL). Each patient is represented by an array report-
ing the logarithm (base 2) of expression level on the set of
9005 genes.
Analytic analysis of the impact of normalization
procedures on diﬀerential expression analysis
In this section, we evaluate the impact of quantile and
rank normalization on t-test. We are especially interested
in studying the asymptotic property of the t-statistic as
the eﬀect size of diﬀerentiation approaches inﬁnity while
other parameters such as n and σ 2i are ﬁxed. Empirical
evidences in Section “Results and discussion” show that
our ﬁndings are also valid for other statistical tests such as
Wilcoxon rank-sum test and permutation based test.
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To simplify theoretical derivation, we assume that the
mean expression levels in the normal phenotype (group
B) are zeros (μBi = 0). This assumption implies that μAi =
μBi + ei = ei. This simpliﬁcation is reasonable because
many hypothesis testing procedures such as t-test and
Wilcoxon rank-sum test are invariant under shift trans-
formation, so the mean diﬀerence between two groups,
ei, is much more important than the normal level of gene
expressions. For simplicity, we also assume that the eﬀect
size is a constant e+ > 0 for all up-regulated and e− < 0








e+ c = A, i ∈ G+1 ,
e− c = A, i ∈ G−1 ,
0 c = A, i ∈ G0,
0 c = B,
(1)
Therefore, the expected group diﬀerences of non-








e+ i ∈ G+1 ,
e− i ∈ G−1 ,
0 i ∈ G0.
(2)
We must point out that all these assumptions are
made only for the simpliﬁcation of the theoretical deriva-
tions. Our ﬁndings essentially do not depend on these
assumptions. This has been conﬁrmed in our biologi-
cal simulation study in Section “Results and discussion”
(SIMU-BIO).













2 is called the pooled sample
standard deviation.
The testing power of a two-sided t-test is determined
by the absolute value of t-statistic. Based on Equation (3),
it is clear that the testing power converges to 100% when
n approaches inﬁnity. For a ﬁxed n (which also implies a
ﬁxed number of degrees of freedom), the testing power
is determined by the absolute sample mean diﬀerence,




we study the asymptotic properties of these two quantities
for quantile and rank normalized expressions separately.
Quantile normalization
With quantile normalization (QUANT), a reference array
of empirical quantiles, denoted as q = (q1, q2, . . . , qm),
is ﬁrst computed by taking the average across all ordered
arrays. Let yc(1),j  yc(2),j  · · ·  yc(m),j denote the
ordered gene expression observations in the jth array (j =
1, 2, . . . , n) of the cth (c = A,B) group, the rth (r =










The original expressions are replaced by the entries of
the reference array with the same rank. Denote rcij as the
rank of ycij in the array to which it belongs. The normalized
gene expressions are














We refer the reader to [3] for more details.
In group A, over(under)-expressed genes tend to have
high (low) ranks in each array. When the eﬀect size is
small, the ranks of DEGs in group A are mixed with those
of NDEGs and the downstream testing power will be low.
When the eﬀect size is large, the DEGs in group A eﬀec-
tively take up all the top and bottom ranks, so the NDEGs
in group A can only compete for ranks between m−1 + 1
and m − m+1 . We assume that the m+1 up-regulated genes
almost always take the top m+1 ranks with equal chances
and the m−1 down-regulated genes almost always take
the bottom m−1 ranks with equal chances. We will show
that the Student’s t-statistic of quantile normalized gene
expressions follows a mixture distribution in which the
doubly noncentral part converges to a distribution with
ﬁnite all order moments instead of inﬁnity when the true
eﬀect size becomes large.
We ﬁrst investigate the asymptotic properties of sample
mean diﬀerence y¯∗Ai· −y¯∗Bi· . Roughly speaking, quantile nor-
malization ranks gene expressions ﬁrst and then replace
them by a reference quantile computed from all arrays.
For an up-regulated DEG (i ∈ G+1 ), its rank can be
among the topm+1 genes for all arrays in the normal group




In this case, the expectation of sample mean diﬀerence is
zero; otherwise it grows linearly as a function of e+. More
speciﬁcally, by using conditional expectation, we obtain
that for i ∈ G+1 ,

















Similarly for down-regulated DEGs (i ∈ G−1 ),
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Detailed derivations can be found in Section 3 in the
Additional ﬁle 1.
Similarly, σˆ ∗·i , the pooled sample standard deviation,
can either grow linearly as a function of e+ and e− or
(with positive probability) stay as a constant. Heuristically
speaking, σˆ ∗·i does not depend on e+ or e− if the ranks of
expressions are all in the top group (r·ij > m−m+1 ), middle
group (m−1 < r·ij  m − m+1 ), or the bottom group (r·ij 
m−1 ) because all expression levels have the same eﬀect
sizes so they are canceled out. If the ranks are from dif-
ferent groups, some will have high expressions and some
are low, the standard deviation will be “stretched out”.
Since we assume up-regulated (down-regulated) genes in
group A almost always take up the top (bottom) ranks,
(σˆ ∗Ai )2 ∝
∑n
j=1(y∗Aij − y¯∗Ai· )2 does not depend on e+ or e−.




















O((e+)2, (e−)2), otherwise with probability












More detailed derivations can be found in Section 3 in the
Additional ﬁle 1.
According to Equations (6), (7) and (8), the sample
mean diﬀerence and pooled sample standard deviation
both grow at most linearly as functions of e+ (e−). As a
result, the (absolute values of ) t-statistics t∗i in (3) (given
rBi1, · · · , rBin) for up-regulated DEGs (i ∈ G+1 ) approxi-
mately have the following mixture of central, noncentral
and doubly noncentral forms:




















O(e+,e−) , otherwise with probability












Similarly, the t-statistics t∗i for down-regulated DEGs (i ∈
G−1 ) approximately have the following mixture forms:




















O(e+,e−) , otherwise with probability












To see this mixture under the normality assumption,
we assume that all observed gene expressions ycij fol-
low a normal distribution. Then, the normalized gene
expressions y∗cij approximately follow a normal distribu-
tion (See Section 2 in the Additional ﬁle 1). According to
Equation (9), the t-statistics t∗i for up-regulated DEGs (i ∈
G+1 ) approximately follow a mixture of central, noncen-
































Here ft , fT(γ) and fT(γ,λ) are the density functions of
central, noncentral and doubly noncentral t-distributions,
respectively, with ν = 2n − 2 degrees of freedom. γ ∝
O(e+, e−) is the numerator noncentrality parameter and
λ ∝ O((e+)2, (e−)2) is the denominator noncentrality
parameter (from noncentral χ2) [35]. Similarly, accord-
ing to Equation (10), the t-statistics t∗i for down-regulated
































In microarray analysis it is reasonable to assume m1 
m, i.e., the proportion of DEGs is small (m−1  m and
m+1  m). So the central t-distribution part in themixture
is negligible. Empirical density functions of t∗i for quantile
normalized DEG expressions with diﬀerent eﬀect sizes are
shown in Figures 1 (b) and (d). For eﬀect sizes 2 and 4,
the two peaks in the center represent the doubly noncen-
tral t-distribution part T(γ, λ) and the two peaks to the far
left and right sides represent the noncentral t-distribution
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(d) With quantile normalization
Figure 1 Empirical density estimates of the t-statistics before and after quantile normalization. Empirical density estimates of the t-statistics
before and after quantile normalization. Gene expression are simulated by using normal random numbers with standard deviation 0.35 and
gene-gene correlation 0.9. Total number of genes ism = 1000. Total numbers of truly diﬀerentially expressed genes arem+1 = 60 for up-regulated
genes andm−1 = 40 for down-regulated genes. The sample size is n = 10 and the true eﬀect size is e+ = −e− = e = {0, 2, 4}. Estimates are based
on 200 repetitions.
partT(γ). The doubly noncentral t-distribution converges
to a distribution with ﬁnite all order moments when e+
(e−) approaches inﬁnity. Figure 1 shows the convergence
of t∗i . Furthermore, we let e+ and −e− vary from 0 to 3.6
and the medians of the t statistic absolute values for DEGs
with and without quantile normalization are plotted in
Figure 2. Clearly, the median for data without normaliza-
tion grows linearly while themedian for data with quantile
normalization is upper-bounded by a ﬁxed constant when
eﬀect size becomes large. Therefore, the testing power
associated with a two-sided t-test cannot reach 100%. The
derivation of this convergence can be found in Section
4 in the Additional ﬁle 1. This result suggests that even
if certain genes are known to have dramatically diﬀerent
expression levels for diﬀerent phenotypes, a typical diﬀer-
ential expression analysis based on quantile normalized
expressions may not be able to detect them. In this case,
combining the results obtained from diﬀerential expres-
sion analysis without normalization may provide new
insight to the underlying biology.
Empirical evidences in Section “Results and discussion”
also show that the statistical power converges to a ﬁxed
number strictly less than 1.0; and this convergence is inde-
pendent of the hypothesis testing methods and MTPs
being applied. Heuristically speaking,QUANT “borrows”
information from both NDEGs and DEGs to reduce data
variation, and as a result the normalized expressions
are complex mixture of both NDEGs and DEGs with
possibly very high true group diﬀerences. Consequently,
the variances of normalized DEGs are asymptotically
dominated by the diﬀerences between the NDEGs and
DEGs and become increasing functions of eﬀect sizes.
Asymptotically, the increased variances cancel out the
contributions of the increased eﬀect sizes to the testing
power.
Rank normalization
With rank normalization (RANK), we replace each entry
in one array by its position (rank) in the ordered array
counted from the smallest value divided by the total
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Figure 2Medians of the t-statistic absolute values.Medians of the
absolute values of the t-statistics for data with and without quantile
normalization. Gene expression are simulated by using normal
random numbers with standard deviation 0.35 and gene-gene
correlation 0.9. Total number of genes ism = 1000. Total numbers of
truly diﬀerentially expressed genes arem+1 = 60 for up-regulated
genes andm−1 = 40 for down-regulated genes. The sample size is
n = 10 and the true eﬀect size is e+ = −e− = e = {0, 0.2, 0.4,
. . . , 3.6}. Estimates are based on 200 repetitions.
number of genes. Denote rcij as the rank of ycij in the array




This method was proposed by [22] and discussed further
in [23].
Compared with QUANT, RANK goes even further in
the nonparametric direction. It removes the noise by only
preserving the ordering of observations. We know m is
usually very large in a typical microarray study. If the eﬀect
size is large such that the over-expressed genes always
take up the top m+1 ranks and the under-expressed genes
always take up the bottom m−1 ranks in group A, y∗cij












m , 1 −
m+1
m ), c = A, i ∈ G0,
U(0, 1), c = B.
(12)
Here for simplicity, again we assume that the genes take
the speciﬁed ranks with equal chances within each group.
Therefore, the normalized gene expressions no longer
depend on the eﬀect size. The expected group diﬀerences











2m i ∈ G+1 ,
m−1
2m − 12 i ∈ G−1 .
(13)
It is easy to check that the pooled standard deviation is
also independent of the eﬀect size. As a result, the testing
power with rank normalization converges to a constant
strictly less than 1.0 as the eﬀect size increases. More
details can be found in Section 5 in the Additional ﬁle 1.
Simulation studies
Extensive simulations are conducted to verify above theo-
retical predictions.We document these simulation studies
in this section.
Simulation data
Two sets of simulated data are used in this study. Each
set of data has two groups of n arrays representing gene
expressions under two phenotypic groups (group A and
group B). The numbers of up and down regulated genes
are denoted by m+1 and m
−
1 , respectively. Without loss of
generality, group B is set to represent the normal pheno-
type, so up (down) regulation of a gene refers to its over
(under) expression in group A.
• SIMU: Each array hasm = 1000 genes. The number
of diﬀerentially expressed genes (DEGs) is set to be
100, which implies that the number of
non-diﬀerentially expressed genes (NDEGs) is
m0 = 900. For both groups, all genes are normally
distributed with standard deviation σ = 0.35 which is
estimated from the biological data. Every two distinct
genes have correlation coeﬃcient 0.9 which is
estimated from the biological data. As a reference, the
sample Pearson correlation coeﬃcient averaged over
all pairs of genes for biological data used in this study
are: 0.91 forHYPERDIP, 0.93 for TEL, and 0.91 for
TALL. The algorithm used to generate these
correlated observations is stated in [36] and is similar
to the method used in [37]. This high correlation
between non-normalized gene expressions can
introduce high correlation between the test statistics
[38] and result in high instability of the list of DEGs.
This phenomenon was documented and discussed in
[39]. We also conduct simulations with
non-homogeneous gene correlation structure and the
results are similar to that of SIMU. Details can be
found in Section 6 of the Additional ﬁle 1.
The expectations of DEGs in group A (yAij , i = 1,
2, . . . ,m+1 + m−1 , j = 1, 2, . . . , n) are set to be a
constant e for over-expressed genes (i = 1, . . . ,m+1 )
and −e for under-expressed genes (i = m−1 + 1, . . . ,
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100). Here the eﬀect size e takes value in {0.2, 0.4, · · · ,
3.4, 3.6}. (m+1 ,m−1 ) is set to be either (60, 40)
(balanced diﬀerential expression structure) or (90, 10)
(unbalanced diﬀerential expression structure). For all
genes in group B and NDEGs in group A, their
expectations are set to be 0. The sample size in each
group is set to be n, taking values in {5, 10}.
• SIMU-BIO: To match the statistical properties of
real gene expression more closely and mimic other
noise sources such as non-additive noise, we apply
resampling method to the biological data to construct
an additional set of data.
We apply t-test toHYPERDIP and TEL (79 arrays
chosen from each set) without any normalization
procedure or multiple testing adjustment. At
signiﬁcance level 0.05, 734 genes are detected as
DEGs with an unbalanced diﬀerential expression
structure (677 up-regulated and 57 down-regulated).
We record the mean diﬀerence acrossHYPERDIP
and TEL for each DEG as its eﬀect size (ei). Then we
combineHYPERDIP and TEL data and randomly
permute the arrays. After that we randomly choose
2n arrays and divide them into two groups A and B
of n arrays each, mimicking two biological conditions
without diﬀerentially expressed genes. Here the
sample size n takes value in {5, 10}. We add the
recorded eﬀect sizes to 734 genes (identiﬁed earlier)
in group A. We also add addition eﬀect size e to 677
up-regulated genes and −e to 57 down-regulated
genes in group A where e takes value in {0, 0.2, 0.4,· · ·,
3.4, 3.6}. These 734 genes are deﬁned as our DEGs in






































































































(d) m +1 = 60 ,m −1 =40 ,n =10
Figure 3 Simulation results (SIMU). Average number of true positives as functions of eﬀect size for SIMU. The error bar represents one standard
deviation above and below average. Total number of truly diﬀerentially expressed genes is 100 withm+1 up-regulated andm
−
1 down-regulated
genes, respectively. Data replicates: 20.





























































































































(d) m +1 = 259 ,m −1 = 287 ,n = 10
0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6
0.0 0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.60.0 0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6
0.0 0.4 0.8 1.2 1.6 2.0 2.4 2.8 3.2 3.6
Figure 4 Simulation results (SIMU-BIO). Average number of true positives as functions of eﬀect size for SIMU-BIO. The error bar represents one
standard deviation above and below average. Total number of truly diﬀerentially expressed genes ism+1 + m11 withm+1 up-regulated andm−1
down-regulated genes, respectively. Data replicates: 20.
procedure to TALL and TEL (45 arrays chosen from
each set) and 546 genes are deﬁned to be DEGs with
a balanced diﬀerential expression structure (259
up-regulated and 287 down-regulated). The sample
size n takes value in {5, 10} and the additional eﬀect
size e takes value in {0, 0.2, 0.4, · · · , 3.4, 3.6}.
Hypothesis testing methods
We use Student’s t-test to compute unadjusted p-values
and then apply the Bonferroni multiple testing adjustment
to compute the adjusted p-values and control the family-
wise error rate (FWER) at 0.05 level.
Two alternative tests, namely the Wilcoxon rank-sum
test and permutation N-test are also used in this study.
The results are largely consistent with those obtained
from the t-test and can be found in Section 6 in the Addi-
tional ﬁle 1. The N-test is a multivariate nonparametric
test which has been used to successfully select dif-
ferentially expressed genes and gene combinations in
microarray data analysis [23,40-42]. A brief introduction
of this test can be found in Section 1 in the Additional
ﬁle 1.
Results and discussion
We randomly generate 20 sets of data per tuning param-
eter for SIMU and SIMU-BIO. We apply normalization
procedures ﬁrst and then conduct hypothesis tests to
obtain raw p-values. After that, we apply the Bonfer-
roni multiple testing adjustment to get adjusted p-values.
We declare a gene to be diﬀerentially expressed if its
adjusted p-value is less than a prespeciﬁed signiﬁcance
level 0.05. The estimated mean and standard deviation of
the true positives are reported in Figures 3 and 4. Various
results with additional tests (Wilcoxon rank-sum test and
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permutation N-test), sample sizes (n = 15, 20) and non-
homogeneous gene correlation structure including false
positive plots can be found in Section 6 in the Additional
ﬁle 1.
By removing the noise from the observed gene
expressions, quantile and rank normalization procedures
improve the statistical power of the subsequent diﬀeren-
tial expression analyses when eﬀect size is small. How-
ever, when e becomes large, the testing powers based on
the normalized expressions converge to ﬁxed numbers
strictly less than 1.0. This conﬁrms our previous theo-
retical derivations.
Conclusions
Microarray technology has been used in many areas of
biomedical research. Biomedical researchers rely on this
technology to identify diﬀerentially expressed genes. Due
to the “large p, small n” nature of themicroarray data, mul-
tiple testing correction must be applied in diﬀerentially
expression analysis. As we all know, stringent control of
Type I error invariably comes with the price of reduced
testing power. However, the success of most microar-
ray studies depends critically on the ability of diﬀeren-
tial expression analysis to identify the “right genes” and
researchers cannot aﬀord to miss many these targets.
High statistical power can be achieved in a study with
the following properties.
1. An adequate sample size. Clearly, this is a reliable
way to increase statistical power. Everyone seems to
agree on it but not everyone practices it. Many years
ago this was due to the high cost of conducting
microarray experiments. Currently it only costs a
fraction to obtain the same number of arrays. In a
sense, the myth that “ﬁve arrays per group should be
good enough” only reﬂects the fact that it takes a long
time to change old, perhaps even anachronic habits.
2. Small variance. It is well known that a large
proportion of the variance of gene expression is
induced by undesirable systematic variations and
various technical noise. Microarray technology has
been evolving very fast in the past years and we think
it is not unreasonable to assume that the technical
noise level is getting lower. However, variance
induced by biological heterogeneity will not be
aﬀected by the advances of technology. For certain
data, using a normalization procedure, such as
QUANT or RANK, can reduce this variance and
help detect DEGs. We must point out that these
elegant variance reduction procedures can also alter
the mean expression and increase sample variance
when the true eﬀect size is large. This bias-variance
trade-oﬀ is common in diﬀerent branches of
statistics and should not be conveniently ignored.
3. Strong true eﬀect size. Based on our experience, this
is often invoked as a reason to justify the use of small
sample size in a study a priori. In our study, we
demonstrate that one cannot simply “trade” sample
size by eﬀect size. Both our theoretical derivations
and simulation studies indicate that as long as the
sample size is small, the testing power of a typical
gene diﬀerential expression analysis based on
quantile or rank normalized data never reaches 100%
no matter how large the eﬀect size is. A large n is still
critical for ﬁnding informative genes in this situation.
One main motivation of our study is to dismiss the dan-
gerous idea that “ﬁve arrays per-group ought to be good
enough for my study”. Our somewhat counter-intuitive
ﬁndings suggest that if data with dramatic gene diﬀeren-
tiation have only limited sample size (e.g., less than 10
per group), rank and quantile normalizations may not
be able to improve testing power as one expects. For
such a scenario we recommend conducting an additional
diﬀerential expression analysis with other normalization
procedure or even without normalization ﬁrst, and then
compare/combine the results with the original analysis
with quantile or rank normalization.
Although we choose to focus on the Aﬀymetrix
GeneChip platform throughout this paper, we believe
our conclusions should be valid for other array plat-
forms which require/recommend normalization, such as
Aﬀymetrix exon arrays, Illumina BeadChip arrays and
many others. We hope this study can help biological
researchers choose an appropriate normalization proce-
dure in their experiments or even develop novel normal-
ization procedures with better downstream testing power
when the gene diﬀerential expression is dramatic.
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